Pseudotumor of the Larynx: A Previously Unreported Side Effect of Apremilast
Apremilast (Otezla®) is a relatively novel orally administered non-biologic disease-modifying anti-rheumatic drug (DMARD) extensively used in the management of psoriasis and psoriasis arthritis, lately approved for treating oral ulcerations in Behçets disease. Its advantageous side effect profile to...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Libro |
| Publicado: |
Karger Publishers,
2020-12-01T00:00:00Z.
|
| Subjects: | |
| Acceso en liña: | Connect to this object online. |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Clasificación: |
A1234.567 |
|---|---|
| Copia 1 | Dispoñible |